InvestorsHub Logo
Post# of 252302
Next 10
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

Re: jq1234 post# 138588

Tuesday, 07/30/2013 9:37:17 PM

Tuesday, July 30, 2013 9:37:17 PM

Post# of 252302
Anti-NGF mAb: PFE disclosed today FDA lifted a partial clinical hold earlier this month on the anti-nerve growth factor (NGF) humanized mAb tanezumab. PFE will resume ph3 trial for chronic pain in 2014.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.